KORU Medical Systems, Inc. 8-K

What Happened

• On March 12, 2026 KORU Medical Systems, Inc. (KRMD) filed a Current Report on Form 8-K (Item 2.02) and issued a press release reporting its financial results for the fourth quarter and full year ended December 31, 2025 and providing financial guidance for the fiscal year ending December 31, 2026. The press release is furnished as Exhibit 99.1. A related conference call is scheduled for March 12, 2026 at 4:30 p.m. Eastern Time.

Key Details

• Press release and earnings disclosure filed March 12, 2026 (Exhibit 99.1).
• Results cover the quarter and full year ended December 31, 2025; guidance provided for fiscal 2026.
• Company will discuss results on a conference call March 12, 2026 at 4:30 p.m. ET.
• KORU discloses and reconciles non‑GAAP measures—“adjusted EBITDA” and “adjusted diluted EPS”—and defines adjustments (e.g., tax benefit/utilization allowances, interest (income)/expense, depreciation & amortization, reorganization charges, tax expense/refund, and stock‑based compensation).

Why It Matters

• This filing gives investors the company’s latest quarterly and annual performance and management’s outlook for 2026. The use of adjusted EBITDA and adjusted diluted EPS provides a supplemental view of operating performance, but KORU cautions these non‑GAAP measures are not replacements for GAAP results and may differ from metrics used by other companies. Investors should review the press release, reconciliations in Exhibit 99.1, and KORU’s full financial statements for a complete picture.